Your browser doesn't support javascript.
loading
RIPK4 promotes bladder urothelial carcinoma cell aggressiveness by upregulating VEGF-A through the NF-κB pathway.
Liu, Jian-Ye; Zeng, Qing-Hai; Cao, Pei-Guo; Xie, Dan; Chen, Xin; Yang, Fei; He, Le-Ye; Dai, Ying-Bo; Li, Jing-Jing; Liu, Xiao-Ming; Zeng, Hong-Liang; Zhu, Yi-Xin; Gong, Lian; Cheng, Yan; Zhou, Jian-Da; Hu, Jun; Bo, Hao; Xu, Zhen-Zhou; Cao, Ke.
Afiliação
  • Liu JY; Department of Urology, The Third Xiangya Hospital of Central South University, 410013, Changsha, China.
  • Zeng QH; Institute of Prostate Disease of Central South University, 410013, Changsha, China.
  • Cao PG; Department of Dermatology, The Third Xiangya Hospital of Central South University, 410013, Changsha, China.
  • Xie D; Department of Onology, The Third Xiangya Hospital of Central South University, 410013, Changsha, China.
  • Chen X; Department of Pathology, Sun Yat-sen University Cancer Center, 510060, Guangzhou, China.
  • Yang F; State Key Laboratory of Oncology in South China, 510060, Guangzhou, China.
  • He LY; State Key Laboratory of Oncology in South China, 510060, Guangzhou, China.
  • Dai YB; Department of Urology, Sun Yat-sen University Cancer Center, 510060, Guangzhou, China.
  • Li JJ; School of Public Health, Central South University, 410078, Changsha, China.
  • Liu XM; Department of Urology, The Third Xiangya Hospital of Central South University, 410013, Changsha, China.
  • Zeng HL; Institute of Prostate Disease of Central South University, 410013, Changsha, China.
  • Zhu YX; Department of Urology, The Third Xiangya Hospital of Central South University, 410013, Changsha, China.
  • Gong L; Institute of Prostate Disease of Central South University, 410013, Changsha, China.
  • Cheng Y; Department of Plastic Surgery, The Third Xiangya Hospital of Central South University, 410013, Changsha, China.
  • Zhou JD; Department of Gastroenterology, The Third Xiangya Hospital of Central South University, 410013, Changsha, China.
  • Hu J; Hunan Key Laboratory of Pharmacodynamics and Safety Evaluation of New Drugs, 410331, Changsha, China.
  • Bo H; Department of Onology, The Third Xiangya Hospital of Central South University, 410013, Changsha, China.
  • Xu ZZ; Department of Onology, The Third Xiangya Hospital of Central South University, 410013, Changsha, China.
  • Cao K; Department of Pharmacology, School of Pharmaceutical Sciences, Central South University, 410008, Changsha, China.
Br J Cancer ; 118(12): 1617-1627, 2018 06.
Article em En | MEDLINE | ID: mdl-29867225
Assuntos
Texto completo
Adicionar na Minha BVS
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Neoplasias da Bexiga Urinária / NF-kappa B / Proteínas Serina-Treonina Quinases / Fator A de Crescimento do Endotélio Vascular Tipo de estudo: Prognostic_studies Limite: Humans Idioma: En Revista: Br J Cancer Ano de publicação: 2018 Tipo de documento: Article País de afiliação: China País de publicação: Reino Unido
Texto completo
Adicionar na Minha BVS
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Neoplasias da Bexiga Urinária / NF-kappa B / Proteínas Serina-Treonina Quinases / Fator A de Crescimento do Endotélio Vascular Tipo de estudo: Prognostic_studies Limite: Humans Idioma: En Revista: Br J Cancer Ano de publicação: 2018 Tipo de documento: Article País de afiliação: China País de publicação: Reino Unido